Relmada Therapeutics Inc (RLMD)
3.35
-0.14
(-4.01%)
USD |
NASDAQ |
May 17, 16:00
3.35
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Free Cash Flow: -48.19M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -48.19M |
| December 31, 2023 | -51.66M |
| September 30, 2023 | -77.29M |
| June 30, 2023 | -92.52M |
| March 31, 2023 | -100.88M |
| December 31, 2022 | -103.80M |
| September 30, 2022 | -105.58M |
| June 30, 2022 | -99.63M |
| March 31, 2022 | -95.22M |
| December 31, 2021 | -91.87M |
| September 30, 2021 | -61.14M |
| June 30, 2021 | -52.73M |
| March 31, 2021 | -40.47M |
| December 31, 2020 | -27.81M |
| September 30, 2020 | -23.41M |
| June 30, 2020 | -14.58M |
| March 31, 2020 | -11.64M |
| September 30, 2019 | -11.36M |
| June 30, 2019 | -10.50M |
| March 31, 2019 | -9.097M |
| December 31, 2018 | -8.710M |
| Date | Value |
|---|---|
| September 30, 2018 | -6.694M |
| June 30, 2018 | -6.014M |
| March 31, 2018 | -4.757M |
| December 31, 2017 | -5.007M |
| September 30, 2017 | -5.328M |
| June 30, 2017 | -6.516M |
| March 31, 2017 | -8.346M |
| December 31, 2016 | -10.16M |
| September 30, 2016 | -12.66M |
| June 30, 2016 | -13.71M |
| March 31, 2016 | -15.35M |
| December 31, 2015 | -16.09M |
| September 30, 2015 | -17.13M |
| June 30, 2015 | -16.25M |
| March 31, 2015 | -11.76M |
| December 31, 2014 | -7.335M |
| September 30, 2014 | -2.351M |
| February 28, 2014 | -0.0249M |
| November 30, 2013 | -0.0225M |
| August 31, 2013 | -0.0119M |
Free Cash Flow Range, Past 5 Years
-105.58M
Minimum
Sep 2022
-10.50M
Maximum
Jun 2019
-58.96M
Average
-52.73M
Median
Jun 2021
Free Cash Flow Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.12M |
| Lifecore Biomedical Inc | -- |
| Harrow Inc | -14.27M |
| Corvus Pharmaceuticals Inc | -20.98M |
| Aquestive Therapeutics Inc | -26.60M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.04M |
| Cash from Investing (Quarterly) | 10.06M |
| Cash from Financing (Quarterly) | 0.2217M |
| Free Cash Flow Per Share (Quarterly) | -0.4327 |
| Free Cash Flow Yield | -47.78% |